Immunonutrition in cancer patients: integrative review

Detalhes bibliográficos
Autor(a) principal: Sousa, Francisco das Chagas Araújo
Data de Publicação: 2020
Outros Autores: Silva, Marta Ferreira da, Silva, Wenderson Costa da, Andrade, Erika Wanessa Oliveira Furtado, Silva, Flavia Dayana Ribeiro da, Santos, Maria Jose Sena dos, Sousa, Karinna Alves Amorim de, Bezerra, Alessandra Kelly Freire, Magalháes, Juliana Macedo, Albuquerque, Keyla Rodrigues de
Tipo de documento: Artigo
Idioma: por
Título da fonte: Research, Society and Development
Texto Completo: https://rsdjournal.org/index.php/rsd/article/view/2004
Resumo: Cancer is a denomination that covers more than 100 types of disease and its main feature is the accelerated growth of abnormal cells that affects the other tissues of the body. Its onset may come from several causes, which may act simultaneously or individually to initiate the process of carcinogenesis. The aim of this study is to demonstrate the benefits of immunomodulators in cancer patients. It is an integrative review with a qualitative approach. To perform this research, a bibliographic survey was made to select studies in the online databases: Virtual Health Library (VHL), Pubmed, Science direct. Regarding the results, the selected studies involved the participation of 15 to 776 patients. Most of these studies were performed using enteral immunonutrition. Participant ages ranged from 18 to 75 years. Studies have shown that immunonutrition had a significant effect on patients with cancer, as it had a positive impact on reducing postoperative complications such as infectious and inflammatory processes, increased serum albumin, reduced length of hospital stay and immune system improvement. The results showed that the immunomodulatory diets were effective in the pre and postoperative period, reducing the possible complications, becoming a safe alternative to optimize the results after the surgical procedures. The articles underscored the importance of knowing when to start nutritional support with supplementation before surgery, as this contributes to good results after treatment.
id UNIFEI_a269236ab7a3382859046daf35629b84
oai_identifier_str oai:ojs.pkp.sfu.ca:article/2004
network_acronym_str UNIFEI
network_name_str Research, Society and Development
repository_id_str
spelling Immunonutrition in cancer patients: integrative reviewInmunonutrición en pacientes con cáncer: revisión integradoraImunonutrição em pacientes oncológicos: revisão integrativaNeoplasiasImunomodulaçãoNutrição.NeoplasiasInmunomodulaciónNutrición.NeoplasmsImmunomodulationNutrition.Cancer is a denomination that covers more than 100 types of disease and its main feature is the accelerated growth of abnormal cells that affects the other tissues of the body. Its onset may come from several causes, which may act simultaneously or individually to initiate the process of carcinogenesis. The aim of this study is to demonstrate the benefits of immunomodulators in cancer patients. It is an integrative review with a qualitative approach. To perform this research, a bibliographic survey was made to select studies in the online databases: Virtual Health Library (VHL), Pubmed, Science direct. Regarding the results, the selected studies involved the participation of 15 to 776 patients. Most of these studies were performed using enteral immunonutrition. Participant ages ranged from 18 to 75 years. Studies have shown that immunonutrition had a significant effect on patients with cancer, as it had a positive impact on reducing postoperative complications such as infectious and inflammatory processes, increased serum albumin, reduced length of hospital stay and immune system improvement. The results showed that the immunomodulatory diets were effective in the pre and postoperative period, reducing the possible complications, becoming a safe alternative to optimize the results after the surgical procedures. The articles underscored the importance of knowing when to start nutritional support with supplementation before surgery, as this contributes to good results after treatment.El cáncer es una denominación que cubre más de 100 tipos de enfermedades y su característica principal es el crecimiento acelerado de células anormales que afectan los otros tejidos del cuerpo. Su inicio puede provenir de varias causas, que pueden actuar de forma simultánea o individual para iniciar el proceso de carcinogénesis. El objetivo de este estudio es demostrar los beneficios de los inmunomoduladores en pacientes con cáncer. Es una revisión integradora con un enfoque cualitativo. Para realizar esta investigación, se realizó una encuesta bibliográfica para seleccionar estudios en las bases de datos en línea: Biblioteca Virtual en Salud (BVS), Pubmed, Science direct. En cuanto a los resultados, los estudios seleccionados incluyeron la participación de 15 a 776 pacientes. La mayoría de estos estudios se realizaron con inmunonutrición enteral. Las edades de los participantes oscilaron entre 18 y 75 años. Los estudios han demostrado que la inmunonutrición tuvo un efecto significativo en pacientes con cáncer, ya que tuvo un impacto positivo en la reducción de complicaciones postoperatorias, como procesos infecciosos e inflamatorios, aumento de la albúmina sérica, reducción de la duración de la estancia hospitalaria y mejora del sistema inmunitario Los resultados mostraron que las dietas inmunomoduladoras fueron efectivas en el período pre y posoperatorio, reduciendo las posibles complicaciones, convirtiéndose en una alternativa segura para optimizar los resultados después de los procedimientos quirúrgicos. Los artículos subrayaron la importancia de saber cuándo comenzar el soporte nutricional con suplementos antes de la cirugía, ya que esto contribuye a obtener buenos resultados después del tratamiento.O câncer é uma denominação que abrange mais de 100 tipos de doença e sua principal característica é o crescimento acelerado de células anormais que afeta os demais tecidos do corpo. Seu surgimento pode ser proveniente de várias causas, estas podem atuar de forma simultânea ou individualmente para dá início ao processo de carcinogênese. O objetivo desse estudo é demonstrar os benefícios dos imunomoduladores em pacientes oncológicos. Trata-se de uma revisão integrativa com abordagem qualitativa. Para a realização desta pesquisa foi feito um levantamento bibliográfico para seleção dos estudos nas bases de dados on-line: Biblioteca Virtual em Saúde (BVS), Pubmed, Science direct. Quanto aos resultados os estudos selecionados envolveram a participação de 15 a 776 pacientes. Grande parte destes estudos foram realizados com a utilização da imunonutrição via enteral. As idades dos participantes variaram dos 18 aos 75 anos. Os estudos demonstraram que a imunonutrição teve um efeito significativo sobre pacientes com neoplasias, visto que a mesma causou um impacto positivo sobre a redução das complicações pós-operatórias, como processo infecciosos e inflamatórios, aumento da albumina sérica, redução do tempo de permanência hospitalar e melhora do sistema imunológico. Os resultados demonstraram que as dietas imunomoduladoras tiveram eficácia no período pré e pós-operatório, reduzindo as possíveis complicações, tornando-se uma alternativa segura para otimizar os resultados após os procedimentos cirúrgicos. Os artigos ressaltaram a importância de conhecer o momento para iniciar o suporte nutricional com a suplementação antes da cirurgia, pois isso contribui para bons resultados após o tratamento.Research, Society and Development2020-01-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://rsdjournal.org/index.php/rsd/article/view/200410.33448/rsd-v9i2.2004Research, Society and Development; Vol. 9 No. 2; e100922004Research, Society and Development; Vol. 9 Núm. 2; e100922004Research, Society and Development; v. 9 n. 2; e1009220042525-3409reponame:Research, Society and Developmentinstname:Universidade Federal de Itajubá (UNIFEI)instacron:UNIFEIporhttps://rsdjournal.org/index.php/rsd/article/view/2004/1740Copyright (c) 2019 Francisco das Chagas Araújo Sousa, Marta Ferreira da Silva, Rian Felipe de Melo Araújo, Evaldo Hipolito de Oliveira, Wenderson Costa da Silva, Luis Alberto de Sousa Rodrigues, Augusto Cesar Evelin Rodrigues, Roseane Mara Cardoso Lima Verde, Francisco Laurindo da Silva, Halmisson Darley Santos Siqueirainfo:eu-repo/semantics/openAccessSousa, Francisco das Chagas AraújoSilva, Marta Ferreira daSilva, Wenderson Costa daAndrade, Erika Wanessa Oliveira FurtadoSilva, Flavia Dayana Ribeiro daSantos, Maria Jose Sena dosSousa, Karinna Alves Amorim deBezerra, Alessandra Kelly FreireMagalháes, Juliana MacedoAlbuquerque, Keyla Rodrigues de2020-08-20T18:08:48Zoai:ojs.pkp.sfu.ca:article/2004Revistahttps://rsdjournal.org/index.php/rsd/indexPUBhttps://rsdjournal.org/index.php/rsd/oairsd.articles@gmail.com2525-34092525-3409opendoar:2024-01-17T09:26:49.572393Research, Society and Development - Universidade Federal de Itajubá (UNIFEI)false
dc.title.none.fl_str_mv Immunonutrition in cancer patients: integrative review
Inmunonutrición en pacientes con cáncer: revisión integradora
Imunonutrição em pacientes oncológicos: revisão integrativa
title Immunonutrition in cancer patients: integrative review
spellingShingle Immunonutrition in cancer patients: integrative review
Sousa, Francisco das Chagas Araújo
Neoplasias
Imunomodulação
Nutrição.
Neoplasias
Inmunomodulación
Nutrición.
Neoplasms
Immunomodulation
Nutrition.
title_short Immunonutrition in cancer patients: integrative review
title_full Immunonutrition in cancer patients: integrative review
title_fullStr Immunonutrition in cancer patients: integrative review
title_full_unstemmed Immunonutrition in cancer patients: integrative review
title_sort Immunonutrition in cancer patients: integrative review
author Sousa, Francisco das Chagas Araújo
author_facet Sousa, Francisco das Chagas Araújo
Silva, Marta Ferreira da
Silva, Wenderson Costa da
Andrade, Erika Wanessa Oliveira Furtado
Silva, Flavia Dayana Ribeiro da
Santos, Maria Jose Sena dos
Sousa, Karinna Alves Amorim de
Bezerra, Alessandra Kelly Freire
Magalháes, Juliana Macedo
Albuquerque, Keyla Rodrigues de
author_role author
author2 Silva, Marta Ferreira da
Silva, Wenderson Costa da
Andrade, Erika Wanessa Oliveira Furtado
Silva, Flavia Dayana Ribeiro da
Santos, Maria Jose Sena dos
Sousa, Karinna Alves Amorim de
Bezerra, Alessandra Kelly Freire
Magalháes, Juliana Macedo
Albuquerque, Keyla Rodrigues de
author2_role author
author
author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Sousa, Francisco das Chagas Araújo
Silva, Marta Ferreira da
Silva, Wenderson Costa da
Andrade, Erika Wanessa Oliveira Furtado
Silva, Flavia Dayana Ribeiro da
Santos, Maria Jose Sena dos
Sousa, Karinna Alves Amorim de
Bezerra, Alessandra Kelly Freire
Magalháes, Juliana Macedo
Albuquerque, Keyla Rodrigues de
dc.subject.por.fl_str_mv Neoplasias
Imunomodulação
Nutrição.
Neoplasias
Inmunomodulación
Nutrición.
Neoplasms
Immunomodulation
Nutrition.
topic Neoplasias
Imunomodulação
Nutrição.
Neoplasias
Inmunomodulación
Nutrición.
Neoplasms
Immunomodulation
Nutrition.
description Cancer is a denomination that covers more than 100 types of disease and its main feature is the accelerated growth of abnormal cells that affects the other tissues of the body. Its onset may come from several causes, which may act simultaneously or individually to initiate the process of carcinogenesis. The aim of this study is to demonstrate the benefits of immunomodulators in cancer patients. It is an integrative review with a qualitative approach. To perform this research, a bibliographic survey was made to select studies in the online databases: Virtual Health Library (VHL), Pubmed, Science direct. Regarding the results, the selected studies involved the participation of 15 to 776 patients. Most of these studies were performed using enteral immunonutrition. Participant ages ranged from 18 to 75 years. Studies have shown that immunonutrition had a significant effect on patients with cancer, as it had a positive impact on reducing postoperative complications such as infectious and inflammatory processes, increased serum albumin, reduced length of hospital stay and immune system improvement. The results showed that the immunomodulatory diets were effective in the pre and postoperative period, reducing the possible complications, becoming a safe alternative to optimize the results after the surgical procedures. The articles underscored the importance of knowing when to start nutritional support with supplementation before surgery, as this contributes to good results after treatment.
publishDate 2020
dc.date.none.fl_str_mv 2020-01-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://rsdjournal.org/index.php/rsd/article/view/2004
10.33448/rsd-v9i2.2004
url https://rsdjournal.org/index.php/rsd/article/view/2004
identifier_str_mv 10.33448/rsd-v9i2.2004
dc.language.iso.fl_str_mv por
language por
dc.relation.none.fl_str_mv https://rsdjournal.org/index.php/rsd/article/view/2004/1740
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Research, Society and Development
publisher.none.fl_str_mv Research, Society and Development
dc.source.none.fl_str_mv Research, Society and Development; Vol. 9 No. 2; e100922004
Research, Society and Development; Vol. 9 Núm. 2; e100922004
Research, Society and Development; v. 9 n. 2; e100922004
2525-3409
reponame:Research, Society and Development
instname:Universidade Federal de Itajubá (UNIFEI)
instacron:UNIFEI
instname_str Universidade Federal de Itajubá (UNIFEI)
instacron_str UNIFEI
institution UNIFEI
reponame_str Research, Society and Development
collection Research, Society and Development
repository.name.fl_str_mv Research, Society and Development - Universidade Federal de Itajubá (UNIFEI)
repository.mail.fl_str_mv rsd.articles@gmail.com
_version_ 1797052645319376896